NCT01896271
Disease Type: Genitourinary
Status: Open
Trial Information
A Phase II Trial of High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Patients with Metastatic Clear Cell Renal Cell Cancer (mRCC)
Click here for more information
This trial is available at:
Methodist Estabrook Cancer Center
8303 Dodge Street, Suite 250, Omaha, NE 68114
Phone: 402-354-8124
Fax: 402-354-8127
Midwest Cancer Center – Legacy
17201 Wright Street, Suite 200, Omaha, NE 68130
Phone: 402-334-4773
Fax: 402-330-7463
Midwest Cancer Center – Papillion
611 Fenwick Drive, Papillion, NE 68046
Phone: 402-593-3141
Fax: 402-593-3145
For more information, please contact: